Paul Tudor Jones Repligen Corp Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Repligen Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 52,755 shares of RGEN stock, worth $8.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

52,755

Holding current value

$8.15 Million

% of portfolio

0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$108.89 - $145.23 $5.74 Million - $7.66 Million	52,755 New	52,755 $6.56 Million
Q3 2023 Nov 15, 2023	BUY	$138.78 - $176.51 $710,969 - $904,260	5,123 New	5,123 $814,000
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $258,871 - $414,283	-1,606 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $397,629 - $488,978	1,606 New	1,606 $425,000
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $789,375 - $1.05 Million	-4,759 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $372,103 - $466,774	-2,063 Reduced 30.24%	4,759 $925,000
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $1.01 Million - $1.41 Million	6,822 New	6,822 $1.31 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $665,120 - $990,524	-7,051 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $599,052 - $769,546	7,051 New	7,051 $681,000
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $2.48 Million - $3.93 Million	-45,742 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $1.18 Million - $1.49 Million	23,798 Added 108.45%	45,742 $2.7 Million
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $1.06 Million - $1.51 Million	21,944 New	21,944 $1.16 Million

Others Institutions Holding RGEN

# of Institutions

507

Shares Held

58.9M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.58B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account